Consumer Sleep-Apnea Features: Capabilities and Limits

Why it matters

Sleep apnea means breathing repeatedly stops and starts during sleep. The NHS lists symptoms including breathing that stops and starts, gasping, snorting or choking noises, waking a lot and loud snoring, and daytime tiredness. [1] It can be serious if not diagnosed and treated. [2] For the condition itself, see Sleep Apnea.

What the FDA authorized

A "De Novo" is the FDA route for a new type of lower-risk device. A "510(k)" shows a device is substantially equivalent to an earlier one. Either way, the clearance covers the specific function and intended use in the FDA documents, not every health claim a company makes about a watch.

What these features are not

• The FDA classification says this type of device is not intended to provide a standalone diagnosis, replace polysomnography (the overnight sleep study), or assist clinicians in diagnosing sleep disorders. [11]
• Apple's feature is not intended to diagnose, treat or aid in the management of sleep apnea, and the absence of a notification is not intended to indicate absence of sleep apnea. [8][12]
• The Samsung feature is not for people already diagnosed. [7] Its labeling says it checks only for possible moderate to severe obstructive sleep apnea and cannot detect central sleep apnea. [13]

How well do they perform? FDA-reported figures

These are from the manufacturers' regulatory submissions as summarized in FDA documents, in specific clinical studies, with specific watches and software. Do not apply them to other devices or versions.

• Samsung: sensitivity 82.7% and specificity 87.7%; the FDA summary notes the specificity result did not pass the study's pre-set acceptance criteria. [14][15] Data were insufficient on 16.7% of nights. [16]
• Apple: sensitivity 66.3% and specificity 98.5% for notifications; the submission says performance was optimized for high specificity because the feature runs passively and repeatedly. [17]

Sensitivity is the share of people with moderate to severe apnea who get flagged. Specificity is the share without it who are correctly not flagged. A feature tuned for high specificity will miss more people who have the condition. Put plainly, a notification is a prompt; silence is not reassurance.

Accuracy is not benefit

These figures describe how well the features match a sleep study in a research setting. They do not show that using them improves health outcomes. We found no study of that in our sources (proper evidence not found).

How to evaluate a claim

Ask: which function is authorized, in which country, for which people, and what did the FDA document say it can and cannot do? Marketing language like "detect sleep apnea" is shorter than the actual indication. The wider American Academy of Sleep Medicine view is that consumer sleep technology cannot be used for diagnosis or treatment of sleep disorders. [19] Note that statement dates from 2018, before these features existed, so it does not address them specifically.